We are monitoring the impact of COVID-19 on North America HPAPI Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2910
Share on
Share on

North America High Potency API Market Research Report – Segmented By Type, Synthesis, Therapeutic Application & Country (The United States, Canada & Rest of North America) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2910
Pages: 145

North America HPAPI Market Size (2021 to 2026)

The size of the North American High Potency API Market was valued at USD 7.05 billion in 2021 and estimated to be growing at a CAGR of 8.9%, to reach USD 10.79 billion by 2026.

High Potency Active Pharmaceutical Ingredients (HPAPI) are pharmacological substances or intermediates which are active at concentrations of 150 micrograms per kilogram of body weight or below. They have high selectivity and usually bind to specific receptors or bind to enzymes which can lead to cancer, reproductive problems, and developmental disorders at low doses. Many new drugs in the market have these high potency active pharmaceutical ingredients leading to the high growth of the market.

These High Potency Active Pharmaceutical Ingredients have a wide range of applications, including cancer. After the mapping of the human genome, cancer drugs could be made not only for different patients but also for different cancers. The production of these drugs is difficult since they are active at very low concentrations and can cause health problems to workers during production and monitoring must be done against contamination of HPAPI production with contaminants. Hence it requires specialized equipment for managing air quality and handling HPAPI’s.

The North America High Potency API (HPAPI) Market has driving factors such as their low price, rising number of pharmaceutical manufacturers and patients, increasing government initiatives to expand the usage of generic medicines to cut down healthcare costs and growing healthcare prices. Some of the constraints faced by this market are the high price of equipment, lack of skilled workers and stringent regulatory requirements.

This research report on the North America HPAPI Market has been segmented and sub-segmented into the following categories:

By Type: 

  • Innovative HPAPI's
  • Generic HPAPI's

By Synthesis: 

  • Biotech HPAPI's
  • Synthetic HPAPI's

By Therapeutic Application: 

  • Oncology
  • Glaucoma
  • Hormonal Balance

By Country: 

  • The United States
  • Canada
  • Rest of North America

Regionally, North America has the largest market in this region is expected to be the fastest-growing. Factors such as the rising incidence of cancer, increasing demand for cancer research and rising funding for cancer-treating HPAPI’s are expected to propel the growth of this market.

Major Companies leading the North America High Potency API Market profiled in this report are Pfizer, Inc. (U.S.), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Eli Lilly and Company (U.S.), Bristol-Myers Squibb (U.S.), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Merck & Co., Inc. (U.S.), AbbVie Inc. (U.S.), and Mylan Inc. (U.S.).

1.Introduction              

               1.1 Market Definition 

               1.2 Study Deliverables

               1.3 Base Currency, Base Year and Forecast Periods        

               1.4 General Study Assumptions               

2. Research Methodology                       

               2.1 Introduction            

               2.2 Research Phases   

                              2.2.1 Secondary Research         

                              2.2.2 Primary Research                         

                              2.2.3 Econometric Modelling   

                              2.2.4 Expert Validation

               2.3 Analysis Design      

               2.4 Study Timeline       

3. Overview                  

               3.1 Executive Summary              

               3.2 Key Inferences       

               3.3 Epidemology          

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                     

               4.1 Market Drivers      

               4.2 Market Restraints 

               4.3 Key Challenges      

               4.4 Current Opportunities in the Market              

5. Market Segmentation           

               5.1 Type          

                              5.1.1 Innovative HPAPI's                       

                              5.1.2 Generic HPAPI's  

                              5.1.3  Y-o-Y Growth Analysis, By Type   

                              5.1.4  Market Attractiveness Analysis, By Type   

                              5.1.5  Market Share Analysis, By Type   

               5.2 Synthesis  

                              5.2.1 Biotech HPAPI's  

                                             5.2.1.1 Biotech High- otency Active Pharmaceutical Ingredients Market, By Type        

        5.2.1.1.1 Innovative Biotech HPAPIs  

        5.2.1.1.2 Biosimilars

                              5.2.2 Synthetic HPAPI's                         

                                             5.2.2.1 Synthetic High Potency Active Pharmaceutical Ingredients Market, By Type       

        5.2.2.1.1 Innovative Synthetic HPAPIs                                                   

        5.2.2.1.2 Generic Synthetic HPAPIs    

                              5.2.3 Y-o-Y Growth Analysis, By Synthesis           

                              5.2.4 Market Attractiveness Analysis, By Synthesis           

                              5.2.5 Market Share Analysis, By Synthesis           

               5.3 Therapeutic Application     

                              5.3.1 Oncology                        

                              5.3.2 Glaucoma                       

                              5.3.3 Hormonal Balance                       

                              5.3.4 Other therapeutic applications     

                              5.3.5 Y-o-Y Growth Analysis, By Therapeutic Application

                              5.3.6  Market Attractiveness Analysis, By Therapeutic Application                        

                              5.3.7  Market Share Analysis, By Therapeutic Application                         

               5.4 Manufacturer        

                              5.4.1 Captive Manufacturers    

                              5.4.2 Merchant Manufacturers

                                             5.4.2.1 Merchant HPAPI Manufacturers Market, By Type          

        5.4.2.1.1 Innovative Merchant HPAPI Manufacturers  

        5.4.2.1.2 Generic Merchant HPAPI Manufacturers       

                                             5.4.2.2 Merchant HPAPI Manufacturers Market, By Type of Synthesis                      

        5.4.2.2.1 Synthetic HPAPIs    

        5.4.2.2.2 Biotech HPAPIs       

                              5.4.3 Y-o-Y Growth Analysis, By Manufacturer   

                              5.4.4  Market Attractiveness Analysis, By Manufacturer 

                              5.4.5  Market Share Analysis, By Manufacturer  

6. Geographical Analysis           

               6.1 Introduction            

                              6.1.1 Regional Trends  

                              6.1.2 Impact Analysis   

                              6.1.3 Y-o-Y Growth Analysis      

                                             6.1.3.1 By Type         

                                             6.1.3.2 By Synthesis                

                                             6.1.3.3 By Therapeutic Application                    

                                             6.1.3.4 By Manufacturer        

                              6.1.4  Market Attractiveness Analysis    

                                             6.1.4.1 By Type         

                                             6.1.4.2 By Synthesis                

                                             6.1.4.3 By Therapeutic Application                    

                                             6.1.4.4  By Manufacturer                      

                              6.1.5  Market Share Analysis     

                                             6.1.5.1 By Type         

                                             6.1.5.2 By Synthesis                

                                             6.1.5.3 By Therapeutic Application                    

                                             6.1.5.4 By Manufacturer        

               6.2 United States         

               6.3 Canada     

7.Strategic Analysis                    

               7.1 PESTLE analysis     

                              7.1.1 Political 

                              7.1.2 Economic                        

                              7.1.3 Social     

                              7.1.4 Technological     

                              7.1.5 Legal      

                              7.1.6 Environmental    

               7.2 Porter’s Five analysis           

                              7.2.1 Bargaining Power of Suppliers  

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Million)
  2. North America Innovative HPAPI's  Market, By Region, From 2021 to 2026 (USD Million)
  3. North America Generic HPAPI's Market, By Region, From 2021 to 2026 (USD Million)
  4. North America High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Million)
  5. North America Biotech HPAPI's Market, By Region, From 2021 to 2026 (USD Million)
  6. North America Synthetic HPAPI's Market, By Region, From 2021 to 2026 (USD Million)
  7. North America High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Million)
  8. North America Oncology Market, By Region, From 2021 to 2026 (USD Million)
  9. North America Glaucoma Market, By Region, From 2021 to 2026 (USD Million)
  10. North America Hormonal Balance Market, By Region, From 2021 to 2026 (USD Million)
  11. North America other therapeutic applications Market, By Region, From 2021 to 2026 (USD Million)
  12. United States High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Million)
  13. United States High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Million)
  14. United States High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Million)
  15. Canada High Potency Active Pharmaceutical Ingredients Market, By Type, From 2021 to 2026 (USD Million)
  16. Canada High Potency Active Pharmaceutical Ingredients Market, By Synthesis, From 2021 to 2026 (USD Million)
  17. Canada High Potency Active Pharmaceutical Ingredients Market, By Therapeutic Application, From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample